Retaliation and Frame2007-2009

Evidence Submission

Chronological Order

Cane and Wallace disburse 16% total over 4 controlled accountsactive shareholders 565

free trading stock 5,926,598.00

restricted stock 8,684,610.00

shares outstanding 14,611,208.00

name Arch Ltd. artist house cede & co Hepburn holdings sunshine ltd the chloe group total wallace/cane holdingstotal other holdings

free trading

holdings 573,847 566,667 2,249,825 573,847 573,847 573,847 2,295,388

16%2,816,492

19%5,111,880

total volume total high total low

13,975,156 $ 6,385,033.92 $ 1,910,412.94

8/31/2007 $ 0.20 $0.25 $0.19 $ 0.20 116,800 $ 29,200.00 $ 22,192.00

8/24/2007 $ 0.25 $0.30 $0.17 $ 0.20 131,600 $ 39,480.00 $ 22,372.00

8/17/2007 $ 0.35 $0.43 $ - $ 0.30 60,100 $ 25,843.00 $ -

8/10/2007 $ 0.31 $0.45 $ - $ 0.33 73,300 $ 32,985.00 $ -

8/3/2007 $ 0.25 $0.44 $0.25 $ 0.35 66,300 $ 29,172.00 $ 16,575.00

7/27/2007 $ 0.35 $0.40 $0.23 $ 0.28 219,900 $ 87,960.00 $ 50,577.00

7/20/2007 $ 0.99 $1.10 $0.31 $ 0.43 1,732,900 $ 1,906,190.00 $ 537,199.00

7/13/2007 $ 0.20 $1.14 $0.20 $ 0.96 1,892,200 $ 2,157,108.00 $ 378,440.00

7/6/2007 $ 0.16 $0.16 $ - $ 0.16 14,000 $ 2,240.00 $ -

6/29/2007 $ 0.16 $0.22 $0.16 $ 0.16 70,800 $ 15,576.00 $ 11,328.00

6/22/2007 $ 0.20 $0.22 $0.11 $ 0.16 140,000 $ 30,800.00 $ 15,400.00

6/15/2007 $ 0.15 $0.15 $ - $ 0.15 45,000 $ 6,750.00 $ -

6/8/2007 $ 0.13 $0.15 $ - $ 0.15 30,500 $ 4,575.00 $ -

6/1/2007 $ 0.14 $0.20 $0.12 $ 0.13 38,700 $ 7,740.00 $ 4,644.00

5/25/2007 $ 0.15 $0.15 $0.07 $ 0.14 83,300 $ 12,495.00 $ 5,831.00

5/18/2007 $ 0.15 $0.20 $0.08 $ 0.13 78,700 $ 15,740.00 $ 6,296.00

5/11/2007 $ 0.19 $0.20 $0.12 $ 0.20 140,500 $ 28,100.00 $ 16,860.00

5/4/2007 $ 0.17 $0.20 $ - $ 0.16 31,000 $ 6,200.00 $ -

4/27/2007 $ 0.25 $0.25 $0.18 $ 0.20 54,300 $ 13,575.00 $ 9,774.00

4/20/2007 $ - $0.50 $ - $ 0.19 9,600 $ 4,800.00 $ -

4/13/2007 $ 0.30 $0.50 $ - $ 0.50 14,800 $ 7,400.00 $ -

4/5/2007 $ 0.22 $0.22 $ - $ 0.16 7,000 $ 1,540.00 $ -

3/30/2007 $ 0.25 $0.30 $ - $ 0.20 28,300 $ 8,490.00 $ -

DAVI SKIN EVENTS, INDIVIDUALS, and STOCK PRICE SHOW SCHEME

MW Medical and DAVI management1. Dotted lines are agent changes, framing Joe Spellman, Josh Levine, and Carlo Mondavi

December 20 2006 (Banana) MetaWallet Nuevatel Agreement

1. Phillips to develop software to track funds including “pass-through accounts” for MetaWallet international accounts.

2. Derivative Future Contracts purchase engine is the key to Banana.

3. Events documented were unknown to Banana and its management and engineers

4. Nuevatel Agreement executed December 20th 2006, with the following promises.

5.

April 3 2007 Jan Wallace issuance 2,295,388 shares

1. 2,295,388 shares of common stock divided into 4 accounts 573,8472. “Unrelated party” is actually “related parties” Hepburn Holdings, Chloe Group of Companies,

Sunshine, Arch Ltd.3. Shares Issued to accounts in April 3 20073. Shares Issued to accounts in April 3 20074. Converted shares are now called derivative securities – financial instrument of MW Medical 5. See Wallace Complaints and Resume

July 14 2008 Wallace, Ambrosio and Cane setting up Gordon.

1. Claire (Ambrosio) is writing up a simple consulting agreement for Ken and arranging for the 556,000 shares to be assigned to him.

April 17 2007, April 23 2007, and Oct 11, 2007 Wallace causes communication with Kevin Gunther (LOM Securities)

June 30 2007 DAVI 10KSB (Cane Securities Attorney, Wallace CEO)

Cont.

June 30 2007 DAVI Skin Derivative Instruments

Wallace framing Phillips with the aid of Kevin Gunther (LOM Securities) with Hepburn and ARCH

mark.phillips

Line

June 30 2007 DAVI SKIN 10KSB

1. On April 3 2007, 2,295,388 shares of the Company’s common stock were issued to unrelated third parties in exchange for extinguishment of debt.

June 30 2007 DAVI SKIN 10KSB

1. 4. Upon receipt and exercise of all derivative securities, provide Mr. Lahka a constant equity position of least 32.9% of the total outstanding equity in our company.

Aberdeen holding company connected to Brian Lines and Scott Lines

• The Lines Brothers are under investigation by the SEC in relationship to the LOM Securities (the brokerage firm of their ownership) and the SEDONA and SHEP Scheme

• SEDONA Software Company is controlled by Cane Clark LLP

• Aberdeen is listed in Dynamic Associates from 2000, MW Medical, • Aberdeen is listed in Dynamic Associates from 2000, MW Medical, Legal Access

LGAL beneficial owner, 2,341,051 shares

Kyleen Cane, uses trans-sexual change, CEDE Depository Trusts, and Tele-lawyer and other derivative agencies, to control and benefit shares while creating the appearance of independence. Michael Cane places shares into CEDE DTC 2,249,825 (50% total volume), Wallace through LOM Securities Nominee Companies comprise of the other 50% free trading volume

DAVI SKIN, INC(Formerly MW Medical, Inc.)

A Development Stage CompanySeptember 30, 2007

NOTES TO FINANCIAL STATEMENTS

In connection with our need for additional financing, we entered into an Agreement for Convertible

Note with an unrelated third party, Mr. Amin S. Lakha, whereby Mr. Lakha is willing to provide, subject to the terms and conditions of the Agreement for Convertible Note and accompanying documents (the “Agreement”), certain financing for our ongoing and proposed business operations and activities. The Agreement provides for a 9% Senior Secured Convertible Note (the “Note”) in the stated amount of $2,200,000. Interest is payable in six month intervals and the note matures on May 15, 2010. The Note allows Mr. Lakha to convert a part or all of the outstanding balance under the Note into shares of our common stock at a conversion price of $0.55 per share, which is under the Note into shares of our common stock at a conversion price of $0.55 per share, which is subject to adjustment in the event of certain dilutive issuances, including stock dividends and reorganizations.

1. Invite Mr. Lakha to serve on our board of directors;

2. Grant Mr. Lakha options to purchase 125,000 shares of our common stock with an exercise price of $0.25 per share;

3. Grant Mr. Lakha warrants to purchase up to 4,000,000 shares of our common stock proportionate to the amount of funds advanced by Mr. Lakha; and

4. Upon receipt and exercise of all derivative securities, provide Mr. Lakha a constant equity position of at least 32.9% of the total outstanding equity in our company.

DAVI SKIN, INC(Formerly MW Medical, Inc.)

A Development Stage CompanySeptember 30, 2007

• DAVI SKIN, INC (Formerly MW Medical, Inc.) A Development Stage Company• September 30, 2007

• NOTES TO FINANCIAL STATEMENTS• On May 4, 2006 we received a letter from legal counsel representing Artist House in which Artist House

purportedly terminated the SPA dated March 27, 2006, and demanded the unconditional return of $1,700,000 million, representing Artist House’s purchase price under the SPA for 566,667 shares of our common stock plus warrants exercisable into 283,333 shares of our common stock. In this demand letter, Artist House alleged that we failed to timely perform certain conditions and obligations under the SPA, including (a) alleged that we failed to timely perform certain conditions and obligations under the SPA, including (a) appointing certain individuals affiliated with Artist House to our board of directors, (b) obtaining directors and officers liability insurance, (c) modifying rights related to stock options issued to our CEO, Joe Spellman, (d) appointing Artist House as our licensing agent in Japan, and (e) requiring board approval for any salary increases to our officers.

• On July 6, 2006, counsel for the Company received written notice from another attorney representing Artist House, demanding rescission of the SPA, based on the similar claims and allegations of breach and nonperformance by the Company and allegations that the alleged “finder” of the investment was acting as an unlicensed broker and therefore the transaction is subject to rescission. The Company denies the allegations.

• Off Balance Sheet Arrangements• As of September 30, 2007, there were no off balance sheet arrangements.

Cane and Wallace purposely stay away until shares are placed and then take over.

MW medical and DAVI shares traded

• Volume of shares traded with corporate events

• 2.2m shares at $1, and par value of LGAL .001 derivative spread provide gains

LGAL (derivative, underlying shares)

• Spun-out of Dynamic Associates (Tele-lawyer)

• Share volume corresponds with reverse merger companies

• LGAL uses equity to back promissory notes • LGAL uses equity to back promissory notes or interest notes in Premiere Exhibitions (bodies exhibit)

• LGAL purchased interest in Carpathia owned by Secure Diversified Investments Robert Saucier shell purchaser for Galaxy Gaming – Washington based casino owner

• Carpathia’s business purpose is to discover Under Sea artifacts

LATI price & volume

DAVI pump & dump July 2007

Wallace requesting Phillips Social

Wallace requesting MOD Amex to purchase personal affects

SEC Filing March 31 2007

• DAVI SKIN, INC• (Formerly MW Medical, Inc.)• A Development Stage Company• March 31, 2007• NOTES TO FINANCIAL STATEMENTS• During April, 2006, we received a letter from a third party requesting the exercise of a conversion right attached to a $200,000

note originally• due to Ms. Jan Wallace, the former CEO of MW Medical. The company is in negotiations presently with Ms. Wallace to convert

the note from• debt to equity. At the year end, the note was still a debt on the books of the company accruing interest. Since then, the debt has • debt to equity. At the year end, the note was still a debt on the books of the company accruing interest. Since then, the debt has

been converted• to equity in the names of third party holders.

• September 30 2007 Filings• During April, 2006, we received a letter from a third party requesting the exercise of a conversion right attached to a• $200,000 note originally due to Ms. Jan Wallace, the former CEO of MW Medical. The company is in negotiations presently• with Ms. Wallace to convert the note from debt to equity. At the year end, the note was still a debt on the books of the• company accruing interest. Since then, the debt has been converted to equity in the names of third party holders.

Company filings events, management position, volume trades, and SEC disclosure events provides patterns and sequence for various schemes.

1. Initial lists and incorporation allows for chaining of companies

and identification of derivative securities.

2. Management and individual tracing allows for association in

fact pattern detection.

3. Registered agent change defines key events when the

association wants to “frame-up” individuals.

4. Equity trades ramp in blocks matching a division of the

business purpose transactions previous recorded. business purpose transactions previous recorded.

5. Blocks or placement of equity are done in multiples or

derivatives.

6. CEDE & CO uses future hybrid contracts to convert underlying

shares to DAVI shares

7. Wallace causes issuance of 4 blocks of 573K shares to off-

shore securities firms.

8. Wallace communicates to associates unidirectional

incriminating evidence without attention to detail on timing.

9. Contract terms with promissory note holders provide back-up

to derivative security and intent of share ownership.

10. Wallace & Cane & associates at the very least are affiliated to

beneficial control entities with undisclosed ownership of

equity and fraudulent statements in filings.

11. The majority of free trading shares are controlled by these

parties and are liquidated into obfuscated accounts.

DAVI sell off period, placement during distraction and take-over 5m shares total

• Blue shaded area cover the days which is believed to occupy the free trading shares

• Future slides show shareholder list matched with 1st hand knowledge of account ownership..

• Right side shows price

• Left side volume • Left side volume

• Shaded area, estimated volume of insider trading

Legal acts as a derivative by its hybrid future contract with spin-outs. LGAL and DAVI allow for multiple directional movements in a concealed fashion or liquidity.

June 5 2007 Secure Diversified Investment Evidence

Wallace uses MW Medical Derivatives shares, Cane uses Legal Access Technologies shares

Galaxy Gaming, hostile take-over SDI

Scheme in play currently, Galaxy Gaming

1. Hostile take-over with Secure Diversified Investments – now shell for Robert Saucier

2. Graph 2 shows moving out of previous company owners and control by Wallace, Cane and Saucier through reorganization

3. Graph 3 shows movement currently in play –October 26 2009

Galaxy Gaming Scheme In progress

1. Unsuspecting company over-taken by Wallace, Munjit and cane team.

2. Shell sold to Saucier as an alter-ego to move funds

3. Saucier owns Carpathia linked to Legal Access Technology

Galaxy Gaming Money Laundering Underway

1. Hybrid promissory notes – such as Lahka provides for exercising of derivative securities.

2. Affiliate companies and securitization of notes or assets allows for tax-less or tax-sheltered

conversion.

Documented Company, Individuals, and Timeline Schemes

Wallace procures controlled substances to gather information.

1. Heather Sandoval

Summary1. SEC v LOM Securities documents Sedona scheme owned by Kyleen Cane, documents LOM

participation in securities fraud including broker-dealer violations provide overview of complex schemes which Cane and Wallace have involvement in.

2. This presentation unravels the Cane Network scheme and their network.

3. All materials have been submitted to Miller Chevalier US Department of Revenue, SEC and other agencies are drafting a complaint which is forthcoming.

4. Network map for Cane, Wallace, Arnold Investments with suspect individuals and proceeds are currently in process. Form 211 may be automated or hand processed by DOJ, SEC, US currently in process. Form 211 may be automated or hand processed by DOJ, SEC, US Treasury or Miller Chevalier

5. Form 211 allows for significant rewards 50% of recovered proceeds and no cap.

6. Current estimated individuals and companies in their scheme exceeds $4.5B and estimated maximum capable $4.5T, which provide for $2B and $2T in form 211 submissions. Revenue forecasts are unknown without research.